The global hub for lifelong cardiovascular learning

Breakthrough pharmacotherapeutic ideas have had a major impact in recent years on the complex treatment of interacting conditions such as diabetes, hypertension and obesity - facilitating earlier and more effective interventions. For the latest CVRM insight, turn to our learning platform.

With an ageing population globally, and predisposing conditions also on the rise, it’s hard to overstate the impact of HF. New insights into managing it and reducing the risk of conditions like cardiomyopathy, begin here: from the latest advances in pharmacotherapies to new digitally-enabled interventions and device therapies.

These courses are an essential step in understanding the treatment, diagnosis and prevention of some of the most common disorders in cardiology: including the latest pharmacological and ablative-based interventions and new implantable devices.

Courses covering the latest advances in pharmacological management and device implantation for N/STEMI and related conditions.

All the established techniques, and the latest innovation, when it comes to intervention. A section dedicated to the growing field of minimally invasive, catheter-based techniques, devices, and procedures.

Preventative cardiology is a field in its own right, overlapping many other specialisms and areas of expertise. Explore the latest advances in lipid and hypertension management.

Over the last two decades, minimally invasive catheter-based techniques have reshaped the treatment of valvular heart disease and related conditions - without ever supplanting surgical intervention as a key component in managing defects. All the latest evidence and opinion from leading physicians can be found here.

Vascular disease is becoming endemic - as the population ages, becomes more obese, and develops conditions like diabetes in ever greater numbers. Since venous and arterial disorders can manifest all over the body, it’s an extremely diverse field. But we’ve got it covered - all the way from anti-thrombotic drugs to increasingly sophisticated micro surgeries.